Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Pulmovant Inc
CONTACT
Lead
Pulmovant, Inc.
This study is a randomized double-blind placebo control study with an extension. The study consists of 2 periods: a blinded placebo-controlled period (24 weeks) and an extension (beyond 24 weeks). Participants will be randomized to receive mosliciguat or placebo in the 24-week double-blind treatment period. All participants who complete the 24-week double-blind period may continue to participate in the extension period where all participants receive mosliciguat.
Age
18–85
Sex
ALL
Healthy volunteers
Not accepted
